Skip to content
    Chicago Pacific Founders logo

    Chicago Pacific Founders

    Chicago, Illinois, United StatesFounded 2014

    Chicago Pacific Founders (CPF) is a strategic healthcare-focused private equity firm based in Chicago. The firm invests in middle-market healthcare companies, care service delivery, and healthcare real estate, deploying up to $75 million per transaction across growth, minority recap, and buyout strategies.

    40% of their portfolio is in Healthcare. Their most common stage is series-b (60% of deals). Average disclosed round size is $74.2M (across 4 rounds with reported amounts).

    Find people at Chicago Pacific Founders on Goldilocks AI

    Portfolio

    4

    Fund Size

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    Greg Kazarian

    Greg Kazarian

    Co-Founding Operating Partner

    John Rijos

    John Rijos

    Co-Founding Operating Partner, CEO of CPF Living Communities

    Lawrence Leisure

    Lawrence Leisure

    Co-Founder and Co-Managing Partner

    Vance Vanier

    Vance Vanier

    Co-Founder and Co-Managing Partner

    Krista Hatcher

    Krista Hatcher

    Co-Managing Partner

    Mary Tolan

    Mary Tolan

    Founder and Managing Partner

    Matt Mainelli

    Matt Mainelli

    Co-Managing Partner

    Aaron Joseph

    Aaron Joseph

    Managing Director, Fund Strategy & Investor Relations

    Cliff Berryman

    Cliff Berryman

    Managing Director / Healthcare Real Estate

    Bert Zimmerli

    Bert Zimmerli

    Operating Partner

    Brian McCarthy

    Brian McCarthy

    Operating Partner, AI & Digital Platforms

    Brie Farmer

    Brie Farmer

    Operating Partner, President & COO, Duo Health

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    GGold Kidney Health PlanGrowth$60MDec 2022
    Tredence logoTredenceSeries B$175MDec 2022
    OMNY Health logoOMNY HealthSeries B$17MNov 2022
    BiointelliSense logoBiointelliSenseSeries B$45MJul 2021
    Tredence logoTredenceGrowth

    Top Co-Investors

    Last updated: 19 September 2026